SynCardia Systems, LLC, articles
Segmented polyurethane solution — the primary material used to manufacture the SynCardia temporary Total Artificial Heart (TAH) — is strong, durable and uniquely suited for use inside the human body.
As a clinically-proven, life-saving treatment option for end-stage biventricular heart failure, patients depend on the SynCardia TAH to provide reliable, long-term support while they wait for a matching donor heart.
The secret behind the success of the Sy
Artificial hearts may sound like science fiction, but they’ve actually been in clinical use to help end-stage heart failure patients for more than 35 years — here’s what you should know.
As the number of patients suffering from heart disease has increased over the years, so too has the need for heart transplants. Unfortunately, the global supply of donor hearts remains limited, and not everyone who needs a heart transplant will receive a matching donor heart in time.
Up to 5,000 American infants and children are diagnosed with pediatric cardiomyopathy each year. Learn more about this rare but potentially serious condition.
Cardiomyopathy, which is a general term for diseases of the heart muscle, is relatively rare in children, affecting only about 12 out of every 1 million Americans under the age of 18.
While heart attack, cardiac arrest and heart failure can sometimes be related, they’re actually three very different types of cardiac emergencies.
Cardiac arrest, heart attack and heart failure — three terms that are familiar to most people, but often get confused with one another. While there can be some overlap between them in terms of cause and effect, they are actually three distinct heart-related issues, each with its own set of causes and treatments.
Watch the inspiring story of heart transplant recipient Marcus Jones.
A devoted father and husband, Marcus Jones never imagined that his heart could threaten to limit his time with loved ones and cut his life short. Yet that’s exactly what happened after Marcus experienced a second aortic aneurysm, and, six months later, was well into biventricular failure.
According to his wife, Cathy, Marcus’s doctors suggested he try a drug that would improve hi
